Kowa Pharmaceuticals America Inc - Company Review
SummaryKowa Pharmaceuticals America Inc - Company Review
Summary
Kowa Pharmaceuticals America Inc (KPA), a subsidiary of Kowa Company Ltd is a drug products manufacturing and distributing company that supplies products in the field of cardiometabolic diseases. The company products include fenofibrate capsules and pitavastatin tablets. Its fenofibrate capsules is an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B and triglycerides. KPA’s markets its products under the brands of LIVALO and Lipofen. The company’s pitavastatin tablets is a prescription medicine used for the treatment of cholesterol. It offers products in the forms of tablets and capsules and distributes products through its wholesalers. KPA is headquartered in Montgomery, Alabama, the US.
This comprehensive company report of Kowa Pharmaceuticals America Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.